Genalyte raises $36 million from Khosla for its one-drop blood test
Theranos competitor Genalyte just announced it has raised an equity round of $36 million in funding led by Khosla Ventures and Redmile Group.
Continue ReadingTheranos competitor Genalyte just announced it has raised an equity round of $36 million in funding led by Khosla Ventures and Redmile Group.
Continue Reading
Join the Discussion